You are here
Valeant CEO cuts outlook for 'distracted' company, shares dive
VALEANT Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a "distracted organisation" with a debt-loaded balance sheet.
The maker of toenail fungus cream Jublia and anti-
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org